Medical Xpress December 14, 2021
Tom Ulrich, Broad Institute of MIT and Harvard

Over the last decade and a half, the biomedical field has witnessed an explosion in the volume and variety of genomic and health-related data. On the one hand, this has been an incredible boon for advancing human health; as our knowledge about the genetics of health and disease grows, so do the opportunities for researchers to make remarkable gains in disease prevention, diagnosis, and treatment.

That explosion, however, has also created immense challenges. Datasets are spread across research centers, universities, health care systems, government agencies, and more, often stored in systems that cannot directly talk to each other or in formats that cannot be readily translated from one to the other. There is a lack of infrastructure that makes it...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article